Hunan Er-Kang Pharmaceutical Co., Ltd (SHE:300267)

SHE:300267 Revenue

Hunan Er-Kang Pharmaceutical had revenue of 247.39M CNY in the quarter ending March 31, 2026, a decrease of -30.03%. This brings the company's revenue in the last twelve months to 1.06B, down -12.96% year-over-year. In the year 2025, Hunan Er-Kang Pharmaceutical had annual revenue of 1.17B with 2.29% growth.

• Revenue (ttm): 1.06B
• Revenue Growth: -12.96%
• P/S Ratio: 7.96
• Revenue / Employee: 729.25K
• Employees: 1,453
• Market Cap: 8.44B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.17B	26.15M	2.29%
Dec 31, 2024	1.14B	-643.51M	-36.09%
Dec 31, 2023	1.78B	-87.42M	-4.67%
Jan 1, 2023	1.87B	-364.76M	-16.32%
Jan 1, 2022	2.24B	-146.97M	-6.17%